Infinium Global Research Equine Pharmaceuticals and Supplements Market | Page 12
Equine Pharmaceuticals and Supplements Market: Global Industry Analysis, Trends, Market Size, and,
Forecasts up to 2023
expected to drive the growth of the equine pharmaceuticals and supplements
market in Middle East. Horse breeding in countries such as Uruguay to cater the
horse racing industry in Middle East and other regions drives the growth of the
Latin American equine pharmaceuticals and supplements market. Horse exporting
nations such as South Africa drive the African equine pharmaceuticals and
supplements market.
MARKET OVERVIEW AND COMPETITIVENESS
DRO ANALYSIS
DRO stands for drivers, restraints and opportunities. The DRO analysis involves,
identifying the factors that are likely to have impact on the global Equine
Pharmaceuticals and Supplements market. It covers analysis of short term and long
term impact of drivers and restraints. Through this analysis both short term and
long term opportunities are identified. These opportunities present the investment
options and new markets for the market players in the Equine Pharmaceuticals and
Supplements market.
Drivers refer to the factors that are expected to drive or boost the market size or
demand for Equine Pharmaceuticals and Supplements. The analysis involves
identification of both demand side and supply side factors that drive the demand as
well as environmental factor that favor the market conditions for growth of Equine
Pharmaceuticals and Supplements market both in short run and long run.
IGR- GROWTH MATRIX ANALYSIS
Growth matrix developed by Infinium Global Research, also known as IGR-Growth
Matrix helps understand the market situation of the business segments. It helps
identify the most attractive segment for the investment purpose and helps the
companies to make better decisions in strategy making. The IGR- Growth Matrix
presents the zones that define the position of the product segment and application
segment based on the market size, growth anticipated and the growth factors &
historic growth. Following are the zones that IGR- Growth Matrix considers
Risky Zone: Low market size and low growth rate. Investment in this segment
is risky
12
|
© Infinium Global Research